The S&P/ASX 200 Index (ASX: XJO) finally recorded a positive day, reversing the four-for-four run of red days this week and closing the week’s trading on a high note.

After some initial wobbles, the ASX 200 spent most of the day in green territory and ended up closing a happy 0.5% higher. That leaves the index at a flat 8,806 points as we head into the weekend.

This optimistic Friday session for Australian investors follows a similarly bullish night on Wall Street.

The Dow Jones Industrial Average Index (DJX: .DJI) was cautiously optimistic, rising by 0.27%.

The tech-heavy Nasdaq Composite Index (NASDAQ: .IXIC) was much more decisive, though, gaining a healthy 1.3%.

But let’s return to the local markets now for a discussion of how the different ASX sectors handled today’s warm trading conditions.

Winners and losers

Despite the market’s sunny disposition today, there were still more than a few sectors that lost ground. 

Chief amongst those were healthcare stocks. The S&P/ASX 200 Healthcare Index (ASX: XHJ) was hit hard today, slumping 1.96%.

Consumer discretionary shares were on the nose as well, with the S&P/ASX 200 Consumer Discretionary Index (ASX: XDJ) sinking 1.13%.

We could say something similar for communications stocks. The S&P/ASX 200 Communication Services Index (ASX: XTJ) drifted 0.83% lower this session.

Tech shares weren’t in the good books either, evidenced by the S&P/ASX 200 Information Technology Index (ASX: XIJ)’s 0.6% tumble.

Consumer staples stocks were in a similar ballpark. The S&P/ASX 200 Consumer Staples Index (ASX: XSJ) shrank by 0.5% this Friday.

We could say the same for industrial stocks, with the S&P/ASX 200 Industrials Index (ASX: XNJ) dipping 0.39%.

Utilities shares got no reprieve. The S&P/ASX 200 Utilities Index (ASX: XUJ) slid down 0.33% this session.

Our final losers were energy shares, illustrated by the S&P/ASX 200 Energy Index (ASX: XEJ)’s 0.21% slip.

Turning to the winners now, the hottest corner of the market was gold stocks. The All Ordinaries Gold Index (ASX: XGD) ended up soaring 2.65% higher.

Broader mining shares were also in demand, with the S&P/ASX 200 Materials Index (ASX: XMJ) surging 2.32%.

Real estate investment trusts (REITs) were a little tamer. The S&P/ASX 200 A-REIT Index (ASX: XPJ) still managed a 0.59% addition, though.

Finally, financial stocks got home safe, as you can see from the S&P/ASX 200 Financials Index (ASX: XFJ)’s 0.55% bounce.

Top 10 ASX 200 shares countdown

Uranium company Silex Systems Ltd (ASX: SLX) was today’s index topper. Silex shares rocketed 9.4% higher to close at $5.70 each this Friday.

This decisive move came despite no obvious catalysts out from the company itself.

Here’s the rest of today’s best: 

ASX-listed company	Share price	Price change
Silex Systems Ltd (ASX: SLX)	$5.70	9.40%
Deep Yellow Ltd (ASX: DYL)	$1.45	7.43%
Mesoblast Ltd (ASX: MSB)	$2.24	6.67%
Capstone Copper Corp (ASX: CSC)	$13.04	6.45%
Resolute Mining Ltd (ASX: RSG)	$0.95	5.56%
South32 Ltd (ASX: S32)	$4.02	5.24%
Ora Banda Mining Ltd (ASX: OBM)	$1.12	5.16%
Develop Group Ltd (ASX: DVP)	$6.03	4.69%
West African Resources Ltd (ASX: WAF)	$2.85	4.40%
Paladin Energy Ltd (ASX: PDN)	$10.06	4.14%

Enjoy the weekend!

Our top 10 shares countdown is a recurring end-of-day summary that shows which companies made big moves on the day. Check in at Fool.com.au after the weekday market closes to see which stocks make the countdown.

The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

More reading

• ASX 200 snaps its losing streak as miners and banks rally
• 9 ASX 200 shares with reiterated buy calls this week
• Mesoblast shares: Q4 earnings top projections
• Ingenia Communities Group shares paused pending announcement
• Why brokers think Zip shares could soar 50% or more in FY27

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 best ASX 200 mining shares for growth in FY26 all more than doubled in value as Australia’s new mining boom continued.

The S&P/ASX 200 Materials Index (ASX: XMJ), dominated by miners, rose 47% and delivered a total return, including dividends, of 52%.

The S&P/ASX 300 Metals & Mining Index (ASX: XMM) rose 53% and produced a total return of 59%.

Experts say there is more growth ahead for ASX mining shares, with 5 key elements underpinning the current commodities supercycle.

Here are two ASX mining shares with buy recommendations from Bell Potter.

The broker believes these two stocks have the potential to more than double in value in the new financial year.

Minerals 260 Ltd (ASX: MI6)

The Minerals 260 share price is 63 cents, up 4.5% today and up 423% over 12 months.

The gold share was the second-fastest riser of the entire ASX 200 in FY26. (See the top five here.)

Minerals 260 is a mineral explorer that is building the Bullabulling Gold Project in Western Australia.  

Bullabulling is one of Australia’s largest near-term gold mines.

This week, Minerals 260 released an updated Mineral Resource Estimate (MRE) and the Pre-Feasibility Study (PFS) for Bullabulling.

The MRE increased 38% to 190Mt at 1.0g/t Au for 6.2Moz.

Bell Potter retained its speculative buy recommendation and lifted its 12-month target to $1.40.

This suggests Mineral 260 shares could more than double in FY27.

The broker said:

MI6 offers gold exposure via the 6.2Moz Bullabulling MRE, valuation uplift through discovery success, project advancement and de-risking as the BGP progresses towards production.

MI6 holds ~$250m cash, sufficient to fund to Final Investment Decision (FID) in early CY27, long-lead items and early site works.

WA1 Resources Ltd (ASX: WA1)

The WA1 Resources share price is $12.31, up 2.5% today and down 24% over 12 months.

Bell Potter has speculative buy rating on this ASX 300 copper share with a $27.20 target.

This suggests WA1 Resources shares could also more than double in the new financial year.

The broker said:

WA1 Resources Ltd (ASX: WA1) has announced scaled-up beneficiation testwork results across four composites representing key Indicated Mineral Resource Estimate (MRE) zones at its 100%-owned Luni Niobium Project (Luni) in Western Australia.

The testwork confirms a two-stage flotation regime can produce high-quality niobium concentrates with commercially relevant recoveries across the deposit, using raw site water.

The testwork is a significant metallurgical data point and materially de-risks the beneficiation stage of the processing flowsheet.

The post 2 ASX mining shares that could more than double in value in FY27: experts appeared first on The Motley Fool Australia.

More reading

• This oversold ASX gold developer could more than double: Broker
• Which ASX 200 sectors paid the highest dividend yields in FY26?
• BHP shares may not double in 12 months but this ASX mining share could
• 5 things to watch on the ASX 200 on Thursday
• 13 ASX 200 shares that doubled in value in FY26

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Aussie share market is on track to finish the week with a much-needed gain.

At the time of writing, the S&P/ASX 200 Index (ASX: XJO) is 0.64% higher at 8,818 points, after briefly reaching 8,821.6 points earlier in the session.

The ASX 200 is now trying to break a run of 4 straight losses, after falling from 8,844 points last Friday to 8,762 points by Thursday’s close.

A stronger night on Wall Street has definitely helped, but the miners and major banks are doing most of the work today.

Here’s how the session is shaping up.

Miners lead the recovery

The S&P/ASX 200 Resources Index (ASX: XJR) is leading the market higher, climbing 2.13% as strength returns to copper, gold and lithium stocks.

BHP Group Ltd (ASX: BHP) shares are 2.74% higher at $58.43, while Rio Tinto Ltd (ASX: RIO) has gained 3.43% to $163.95.

South32 Ltd (ASX: S32) is one of the stronger performers, rising 5.37% to $4.025.

Gold miners are joining the move, with Evolution Mining Ltd (ASX: EVN) shares up 4.31% to $11.735 and Northern Star Resources Ltd (ASX: NST) adding 2.43% to $20.62.

Banks provide more support

The major banks are adding to the gains, with all of them trading higher.

Commonwealth Bank of Australia (ASX: CBA) shares have gained 0.74% to $169.35, while Westpac Banking Corp (ASX: WBC) is 1.05% higher at $36.58.

National Australia Bank Ltd (ASX: NAB) has added 0.79% to $39.59, and ANZ Group Holdings Ltd (ASX: ANZ) is up 1.15% to $36.17.

Macquarie Group Ltd (ASX: MQG) is also in positive territory, rising 0.78% to $254.16.

The miners and banks are doing most of the work for the index, but the rest of the market is still holding up reasonably well.

Around 109 of the ASX 200 shares are higher, compared with 75 trading lower and 16 unchanged.

Not every sector is joining in

The gains aren’t being shared evenly, with consumer discretionary, healthcare and energy stocks trading lower.

Wesfarmers Ltd (ASX: WES) shares are down 1.18% to $89.80, while Aristocrat Leisure Ltd (ASX: ALL) has slipped 0.97% to $61.795.

Healthcare is also weighing on the market. CSL Ltd (ASX: CSL) is 1.49% lower at $123.66, while Pro Medicus Ltd (ASX: PME) has fallen 3.74% to $202.56.

Woodside Energy Group Ltd (ASX: WDS) shares are down 0.92% to $29.03 as oil prices remain volatile.

Nonetheless, Wall Street’s overnight rebound helped sentiment. The S&P 500 Index (SP: .INX) rose 0.81%, the Nasdaq Composite Index (NASDAQ: .IXIC) gained 1.3%, and the Dow Jones Industrial Average (DJX: .DJI) added 0.27% as tech shares recovered and oil prices eased from their earlier spike.

After 4 days in the red, the ASX 200 is at least on track to finish the week with a gain.

The post ASX 200 snaps its losing streak as miners and banks rally appeared first on The Motley Fool Australia.

More reading

• 3 ASX mining shares to buy now: experts
• 9 ASX 200 shares with reiterated buy calls this week
• Here’s what brokers tip for BHP shares over the next 12 months
• Mesoblast shares: Q4 earnings top projections
• Ingenia Communities Group shares paused pending announcement

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Macquarie Group, and Wesfarmers. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended BHP Group, CSL, Macquarie Group, Pro Medicus, and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) mining shares experienced an outstanding year in FY26.

The ASX 200 materials sector, dominated by miners, was the best of the 11 market sectors, rising 47% and returning 52% in total.

The S&P/ASX 300 Metals & Mining Index (ASX: XMM), which captures more of the explorers than the ASX 200, did even better.  

ASX 300 mining shares rose 53%, and delivered a total return of 59%.

Australia is in the midst of a new mining boom driven by five key elements.

Many commodities rose in value in FY26, which boosted the earnings of the 5 best ASX 200 mining shares of the year.

Here, we look at three ASX mining shares that brokers recommend buying now for FY27.

BHP Group Ltd (ASX: BHP)

The BHP share price is up 2.6% to $58.35 today, and up 52% over 12 months.

BHP was one of the best performers for capital growth amongst the ASX 200 large-cap shares last year.

Blake Halligan from Catapult Wealth explains his buy rating on BHP shares:  

The global miner holds dominant positions in iron ore and copper and is leveraged to increasing demand during the energy transition.

Despite the Jansen impairment and the risk of industrial action at iron ore operations in the Pilbara region of Western Australia, near term earnings momentum remains strong.

The balance sheet remains robust with low net debt, while a recent dividend yield above 3 per cent adds income appeal.

Read more about what the experts anticipate for BHP shares over the next 12 months.

Nickel Industries Ltd (ASX: NIC)

The Nickel Industries share price is 89 cents, up 2.3% today and up 21% over 12 months.

Bell Potter has a buy rating with a 12-month price target of $1.55 on this ASX 300 nickel share.

This implies potential capital growth of almost 75% over the next 12 months.

The broker said:

NIC offers nickel price leverage and diversified margin exposure across an integrated value chain.

The HPAL expansion transactions will further balance NIC’s earnings into downstream higher-margin operations and preserve earnings through the nickel price cycle.

Maronan Metals Ltd (ASX: MMA)

The Maronan Metals share price is 43 cents, down 1.2% today and up 93% over 12 months.

Maronan is developing a silver-lead and copper-gold deposit in Queensland’s Cloncurry region.

The mine is one of Australia’s largest undeveloped silver-lead and copper-gold deposits.

Morgans initiated coverage on this ASX silver share with a speculative buy call and a 66-cent target this month.

This implies a potential 53% upside over the next 12 months.

The broker said:

The wholly-owned Maronan Mineral Development Lease (MDL 2028) was approved in September 2025, after the Preliminary Economic Assessment (PEA) evaluated a 10-year underground mine life based on 22% of the total resource.

The resource to JORC Code (2012) standards contains 122Moz silver, 2Mt lead, 271kt copper and 0.76Moz gold, with yearly production 5.4Moz silver equivalent (AgEq) at an all-in sustaining cost (AISC) of A$30.18/oz (~US$20/oz) AgEq.

While the PEA is robust, MMA is yet to deliver a feasibility study, secure development finance, receive grant of a Mining Lease, and commence the path from construction to production.

With 40-45% exposure to silver and 20-25% to lead, commodity prices are also the key to the level of profitability.

The post 3 ASX mining shares to buy now: experts appeared first on The Motley Fool Australia.

More reading

• ASX 200 snaps its losing streak as miners and banks rally
• 9 ASX 200 shares with reiterated buy calls this week
• Here’s what brokers tip for BHP shares over the next 12 months
• The bull and bear case for CBA and BHP shares
• Which ASX 200 sectors paid the highest dividend yields in FY26?

Motley Fool contributor Bronwyn Allen has positions in BHP Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Few ASX stocks have given investors a more brutal ride than WiseTech Global Ltd (ASX: WTC) this year.

The WiseTech share price has fallen 50% since the start of 2026 and is now trading a long way below its 52-week high of $121.31.

At the time of writing, the stock is down another 1.21% on Friday to $34.21, taking its monthly decline to around 10%.

However, WiseTech has recovered from its low of $28.76 on 23 June. The stock has posted several large daily gains over the past few weeks, although those rallies have often been followed by more selling.

Investors are now weighing comments from management about one of the company’s largest customers, while trying to work out whether the recent low has finally marked the bottom.

Here’s the latest.

WiseTech tries to ease customer concerns

According to The Australian, WiseTech Chief Executive Zubin Appoo is trying to settle concerns about Danish logistics group DSV.

DSV completed its 14.3-billion-euro takeover of DB Schenker in April 2025, creating one of the world’s largest transport and logistics companies.

The issue that’s taking centre stage is that DSV could eventually replace WiseTech’s CargoWise software with Tango, the system acquired through DB Schenker.

However, Appoo said DSV remains an active WiseTech customer and continues to increase its use of CargoWise.

He said:

DSV remains an active WiseTech customer. CargoWise transaction volumes with DSV have grown by around 20 per cent in the last six months.

Take note, the number of DSV users on CargoWise has reportedly increased by around 3% over the same period.

Appoo recently met with DSV Chief Executive Jens Lund and said both companies remain committed to their long-term relationship. DSV’s current contract runs until September 2028.

WiseTech pointed out that large CargoWise installations can take between 5 and 7 years to complete. And that customer attrition has remained below 1% a year over the past 14 years.

Investors are not convinced yet

Despite the reassurance, analysts at Citi still see the potential DSV migration as a risk.

The broker has warned about the issue since February and again highlighted “DSV migration headwinds” this week.

Citi has reportedly reduced its FY28 CargoWise revenue growth forecast to 7%, removing around $80 million from its previous estimate.

This means that the downgrade shows Citi is allowing for some impact, even though DSV hasn’t confirmed it will leave CargoWise.

Has the WiseTech share price bottomed?

There are signs that buyers are stepping in around the low-$30 mark, but the stock is still moving around a lot.

WiseTech shares jumped 14.26% on 24 June, then rose another 7.31% and 5.65% earlier this week. The stock gave back 7.28% on Wednesday.

Keep in mind, the business is still profitable, and CargoWise is widely used across the logistics industry.

And DSV hasn’t confirmed any plans to leave the platform either.

The share price could remain under pressure in the short term, but a stronger-than-expected August result could help shift the mood.

The post Has the WiseTech share price finally hit the bottom after crashing 50%? appeared first on The Motley Fool Australia.

More reading

• 9 ASX 200 shares with reiterated buy calls this week
• Two ASX tech shares hinge on rebuilding trust and growth. Here’s how they can turn around
• How low could WiseTech shares go?
• Why the WiseTech share price is sinking 7% today
• 2 ASX shares tipped to grow 50% or more in the next 12 months

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

4DMedical Ltd (ASX: 4DX) shares took a breather during Friday’s session, edging 1% higher to $4.10.

The healthcare technology company has pulled back around 12% over the past six months and now trades roughly 46% below the record high it reached in April.

However, the longer-term picture looks very different. This ASX healthcare share is still up an astonishing 1,636% over the past 12 months. Yes, that’s more than sixteen-fold in just one year.

So, after such an extraordinary run, could 4DMedical shares eventually reclaim their all-time high?

Why investors have become so bullish

The biggest catalyst behind the remarkable rise of 4DMedical shares has been growing confidence in its commercial prospects.

The company has developed proprietary respiratory imaging technology that produces four-dimensional lung scans, giving doctors significantly more information than traditional imaging methods. The technology has applications across chronic respiratory diseases, lung cancer, and surgical planning.

Importantly, management has shifted its focus from proving the technology to commercialising it.

US growth and AI investments

Over the past year, 4DMedical has secured several significant contracts and partnerships across the US. Recently, the business signed a major agreement with SimonMed, helping expand its CT:VQ lung imaging technology across the US.

Management believes the deal could lift its addressable market to around US$3 billion with major healthcare providers and government agencies. These agreements have strengthened investor confidence that revenue growth can accelerate as adoption increases.

The company has also continued investing in artificial intelligence capabilities to expand the usefulness of its imaging platform and create additional opportunities within respiratory care.

The path back to record highs

For 4DMedical shares to revisit their April peak, investors will likely need further evidence that commercial momentum is translating into sustainable financial results.

Like many emerging healthcare technology companies, 4DMedical remains focused on scaling its business rather than generating large profits today. That means investors are placing significant value on its future growth potential.

Continued contract wins, increasing scan volumes, expanding recurring revenue, and progress in the US healthcare market could all help support a higher valuation over time.

Heavy investments in research

Despite its enormous gains, 4DMedical remains a higher-risk investment.

Commercialising new medical technology can take longer than expected. Particularly, when healthcare providers require clinical validation and budget approvals before adopting new products.

The company also faces competition from established medical imaging businesses and must continue investing heavily in research, product development, and sales to maintain its competitive advantage.

As a high-growth healthcare stock, 4DMedical shares are also likely to remain volatile. Even positive companies can experience large share price swings as investor sentiment shifts.

The post Up 1,636%, but can 4DMedical shares reclaim their record high? appeared first on The Motley Fool Australia.

More reading

• Which ASX 200 sectors paid the highest dividend yields in FY26?
• This red-hot ASX healthcare share hit a speed bump. What next?
• 13 ASX 200 shares that doubled in value in FY26
• 2 ASX 200 healthcare shares to buy after sector rebounds 23% in a month
• These are the 10 most shorted ASX shares

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Minerals 260 Ltd (ASX: MI6) this week released the results of a prefeasibility study into its Bullabulling gold project in Western Australia, and it’s fair to say the market was underwhelmed.

While the stock is up more than 440% over the past 12 months, the shares dipped slightly on the publication of the PFS and are now trading at 62 cents.

The analysts at Morgans believe this is cheap and have a bullish share price target on the gold company’s shares, which we’ll get to later.

First, let’s look at what they announced.

Major, long-life gold project in development

The company said in a statement to the ASX that Bullabulling would generate average annual free cash flow of $330 million and would operate for 19 years.

The company would spend $180 million from existing cash reserves to get to a final investment decision, while the mine would cost $560 million to build, plus another $115 million for pre-production operations.

A definitive feasibility study was expected to be completed in the first quarter of calendar year 2027.

Minerals 260 Managing Director Luke McFadyen said regarding the project:

Fifteen months after acquiring the Bullabulling Gold Project, we are presenting outcomes of our PFS and a Maiden Ore Reserve. We always believed Bullabulling could become a significant gold operation, and today’s outcomes confirm the potential for this high-margin, large-scale, long-life Project. Our target of delivering Bullabulling into production by the end of 2028 will establish Minerals 260 as the next mid-tier gold producer on the ASX. With an NPV of $2.3 billion, an IRR of 43% and $510M of average annual EBITDA, Bullabulling is set to deliver significant growth and value for our shareholders.

Shares in this ASX gold company looking cheap

Morgans said, importantly, that the PFS was completed using the previous 4.5 million-ounce gold resource, with an upgraded 6.2 million-ounce resource providing scope for further resource growth.

They added:

The market has reacted negatively to the PFS, which we believe is largely a product of the crystallisation of a sizeable upfront capital requirement rather than any deterioration in project quality. While pre-production capital of ~A$855m is significant, we view it as appropriate for an asset of Bullabulling’s scale, longevity and economic returns, with the project’s strong cash-generative profile expected to support favourable financing outcomes.

Morgans is anticipating first production in mid FY29 with an average output of about 150,000 ounces per year initially.

They added:

We assume a Stage 2 expansion, funded from operating cash flow, is commissioned in 2H FY31, increasing production towards ~200kozpa. Beyond lifting the production profile, the larger-scale operation has the potential to benefit from economies of scale and lower unit operating costs, although we do not currently incorporate these benefits into our base case.

Morgans has a price target of $1.38 on Minerals 260 shares.

The post This oversold ASX gold developer could more than double: Broker appeared first on The Motley Fool Australia.

More reading

• Which ASX 200 sectors paid the highest dividend yields in FY26?
• BHP shares may not double in 12 months but this ASX mining share could
• 5 things to watch on the ASX 200 on Thursday
• 13 ASX 200 shares that doubled in value in FY26
• 5 best ASX 200 mining shares of FY26

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are 0.5% higher on Friday at 8,801.8 points.

Brokers have indicated continuing confidence in several ASX 200 shares this week.

Let’s take a look.

Telstra Group Ltd (ASX: TLS)

The Telstra share price is $4.99, up 0.1% today and up 2.2% over 12 months.

Morgan Stanley reiterated its buy rating on Telstra shares on Wednesday.

The broker lowered its 12-month share price target from $5.40 to $5.30.

This implies potential capital gains of 6% in FY27.

Liontown Ltd (ASX: LTR)

The Liontown share price is $1.47, down 0.5% today and up 83% over 12 months.

The lithium producer was one of the 5 top ASX 200 mining shares for capital growth in FY26.

Macquarie renewed its buy rating on Liontown shares with a $2.30 target this week.

This suggests a potential 57% upside ahead.

Life360 Inc (ASX: 360)

The Life360 share price is $25.82, down 0.4% today and down 21% over 12 months.

Citi reiterated its buy rating on Life360 shares on Tuesday.

The broker raised its target from $28.25 to $31.95.

This implies potential capital gains of 24% ahead.

Pro Medicus Ltd (ASX: PME)

The Pro Medicus share price is $199.48, down 5.1% today and down 37% over 12 months.

However, that 12-month performance belies this ASX 200 healthcare share’s incredible comeback in CY26.

Pro Medicus shares hit a 52-week low of $107.75 on 24 February. Since then, they’ve ripped 85% higher.

And since the broader healthcare sector pivoted on 3 June, Pro Medicus shares have outperformed with a 25% gain.

That compares to a 21% increase in the S&P/ASX 200 Health Care Index (ASX: XHJ) since 3 June.

Citi sees more room for growth, and reiterated its buy rating with a $240 target this week.

This suggests another 20% upside ahead.

South32 Ltd (ASX: S32)

The South32 share price is $4.02, up 5.2% today and up 32% over 12 months.

Morgan Stanley maintained its buy rating on the ASX 200 mining share this week.

The broker shaved its 12-month target down from $4.85 to $4.75.

This implies a potential 18% upside ahead.

BHP Group Ltd (ASX: BHP)

The BHP share price is $58.28, up 2.5% today and up 52% over 12 months.

Morgan Stanley renewed its buy rating on BHP shares with a $67.50 target this week.

This suggests a potential 15% upside in the new financial year.

WiseTech Global Ltd (ASX: WTC)

The WiseTech share price is $34.24, down 1.1% today and down 70% over 12 months.

This tech share was the fastest faller of the ASX 200 in FY26.

Citi anticipates a strong recovery for WiseTech shares and renewed its buy rating this week.

However, the broker cut its 12-month target significantly from $65.65 to $52.

This still implies potential capital gains of 52% in FY27.

Paladin Energy Ltd (ASX: PDN)

The Paladin Energy share price is $10.15, up 5.1% today and up 46% over 12 months.

Morgan Stanley kept its buy call on the ASX 200 energy share but lowered its target from $13.65 to $11.95 this week.

This suggests a potential 17% upside ahead.

Coles Group Ltd (ASX: COL)

The Coles share price is $23.58, down 0.4% today and up 15% over 12 months.

UBS renewed its buy rating on the ASX 200 consumer staples share with a $25.50 target on Monday.

This suggests a potential 8% upside ahead.

The post 9 ASX 200 shares with reiterated buy calls this week appeared first on The Motley Fool Australia.

More reading

• Here’s what brokers tip for BHP shares over the next 12 months
• Which is the best buy, Coles shares or Wesfarmers shares?
• Two ASX tech shares hinge on rebuilding trust and growth. Here’s how they can turn around
• The bull and bear case for CBA and BHP shares
• How much do I need in my superannuation to get $52,000 per year in passive income?

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has positions in BHP Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, Macquarie Group, and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Life360, Telstra Group, and WiseTech Global. The Motley Fool Australia has recommended BHP Group, Macquarie Group, and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Most investors wouldn’t think of drones initially when thinking of Codan Ltd (ASX: CDA), with the company having traditionally based its business around radio communications technology and metal detector sales.

But the company’s DTC division, which it acquired back in 2021, has developed radio technology for use on drone platforms, which has piqued the interest of the analysts at Macquarie.

Major opportunity for ASX drone players

The Macquarie team said in a recent note to clients that there is expected to be exponential growth in drone spending, citing a recent NATO initiative called “drone edge”, which envisages US$40 billion worth of investment in the sector from more than 30 countries.

They added:

As we mentioned in a previous report, the US Department of War’s 2027 budget overview includes US$53.6bn in funding for drone and autonomous systems and US$21bn for counter drone technologies. This dedicated investment into autonomous systems’ procurement, domestic production capacity and advanced capabilities is being divided across multiple specialised programs.

They said in relation to Codan:

When encompassing estimated communication layer drone costs and US-specific programs, together these frame a large, multi-year, structurally growing US demand pool that plays directly to DTC’s niche. DTC’s key offering of resilient datalink, mesh-networking and electronic warfare hardened communications layer is directly linked to various components that multi-domain drone and unmanned systems require.

The Macquarie team said beyond the US, “DTC also has significant opportunities in the European region as noted by management back at the 1H26 result”.

They added:

Europe has emerged as a structurally attractive opportunity as the recent step-change in defence spending driven by the war in Ukraine and NATO eastern-flank deterrence is flowing into unmanned-systems and resilient communications categories where DTC competes.

Macquarie said the Asia-Pacific region was also shaping up as one of the most compelling regions for DTC, driven by a surge in defence spending.

Australia itself was a “high-conviction oppoprtunity”, with the company’s radios already selected for the Land 129 UAV project.

Macquarie added regarding the company:

To meet surging international demand for secure communications solutions as a part of the increasing demand for drones and uncrewed systems, DTC has established a multi-country manufacturing footprint, expanding production outside the US. The newer established manufacturing locations for DTC, the United Kingdom and Australia, help to de-risk global supply chains. This expansion in manufacturing positions DTC well to capture opportunities across different regions globally.

Shares looking cheap

Macquarie has a price target of $48.50 on Codan shares compared with $43.25 currently.

The company is valued at $8.09 billion.

The post How high does Macquarie think this ASX drone technology company will go? appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Which ASX 200 sectors paid the highest dividend yields in FY26?
• 13 ASX 200 shares that doubled in value in FY26
• ASX 200 tech shares tanked in FY26, but there were 3 winners
• Top ASX 200 share of each market sector in FY26

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Elevra Lithium Ltd (ASX: ELV) shares are slipping on Friday after the lithium producer released an early look at its June quarter.

At the time of writing, the Elevra Lithium share price is down 4.54% to $8.62. By comparison, the S&P/ASX 200 Index (ASX: XJO) is up 0.5% to 8,809 points.

Despite today’s decline, Elevra shares remain up around 7% in 2026 and have climbed roughly 220% since this time last year.

The latest numbers included another strong quarter at the mine, although the lower price received for its lithium appears to be weighing on the stock.

Here’s what the company reported.

Production finishes the year strongly

According to the release, Elevra produced approximately 54,479 dry metric tonnes (dmt) of spodumene concentrate during the June quarter.

Production rose 15% from the March quarter and marked the second-highest quarterly result achieved at North American Lithium.

The operation delivered a particularly strong May, producing approximately 22,202 tonnes. Elevra described this as a monthly production record.

Full-year production reached approximately 197,968 tonnes, giving the company a stronger finish to FY26.

Management put the improvement down to continued work on plant optimisation, ore feed consistency, and recoveries. The company also pointed to throughput and operating efficiency gains across the quarter.

However, sales didn’t keep pace with production.

Sales came in at around 33,977 tonnes, which the company linked to customer delivery schedules.

As a result, Elevra finished June with a provisional inventory of around 40,863 tonnes.

Pricing takes the shine off production gains

The price Elevra received for its lithium was less than impressive.

The company reported provisional average realised pricing of approximately US$919 per tonne, sold free on board.

Management said June shipments were priced under contracts linked to average market prices between October 2025 and March 2026.

Lithium prices were lower through much of that period, which left Elevra receiving less than the current spot market.

The June quarter sales were also made under the company’s largest legacy contract, which uses the same delayed pricing structure.

Currently, the spot price for lithium is sitting at 158,500 CNY, down 3.35% for the day.

Can Elevra shares recover?

I think Elevra shares can recover from here.

Production is improving, and the pricing lag should start to ease as more sales move onto newer contracts.

The next step is to turn that higher output into better sales and cash flow, particularly after inventory increased during the quarter.

The full quarterly report later this month should show whether higher production is starting to improve the rest of the business.

The post Why record production could not save this ASX lithium stock today appeared first on The Motley Fool Australia.

More reading

• Top 5 ASX 200 lithium shares of FY26
• 13 ASX 200 shares that doubled in value in FY26
• 5 best ASX 200 mining shares of FY26
• ASX shares vs. property in FY26: Which investment outperformed?
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.